Does Fallon Community Health Plan (FCHP) Cover Viagra?

How Fallon Health Formularies Handle Erectile Dysfunction Drugs

Fallon Health (formerly Fallon Community Health Plan) maintains a tiered formulary that categorizes medications by cost and clinical preference. Generic sildenafil sits on most FCHP commercial formularies as a Tier 2 or Tier 3 drug, meaning members pay a moderate copay rather than full retail price. Brand-name Viagra (sildenafil citrate, Pfizer) is frequently listed as non-preferred or excluded entirely.

The distinction matters financially. A 2023 analysis of commercial plan formularies in Massachusetts found that 89% of regional health plans covered generic sildenafil while only 34% maintained brand Viagra without restriction [1]. Fallon Health follows this broader pattern. Members with commercial HMO or PPO products through Fallon can typically fill generic sildenafil prescriptions with copays ranging from $10 to $45, depending on the specific benefit design selected by their employer group.

Fallon Health updates its formulary quarterly. The Pharmacy and Therapeutics (P&T) Committee reviews new evidence, pricing changes, and FDA label modifications before each update. Members should verify current coverage status through the online formulary search tool at fallon health's member portal or by calling the number on the back of their member ID card.

Prior Authorization and Step Therapy Requirements

Most FCHP plans require a confirmed diagnosis of erectile dysfunction before approving sildenafil coverage. The prescribing clinician must document the medical necessity using ICD-10 code N52.01 (erectile dysfunction due to arterial insufficiency), N52.1 (erectile dysfunction due to diseases classified elsewhere), or related codes in the N52.x family.

For brand-name Viagra specifically, Fallon Health typically imposes step therapy. This means the member must first try and fail generic sildenafil before the plan will authorize the brand product. "Fail" generally means documented adverse effects, therapeutic failure at maximum dose (100 mg), or a pharmacologically valid contraindication to the generic formulation's inactive ingredients.

The prior authorization process at Fallon Health takes 24 to 72 hours for standard requests. Urgent requests receive a decision within 24 hours. The prescriber submits clinical documentation showing the diagnosis, previous treatments attempted, and rationale for the requested medication. According to AUA guidelines on erectile dysfunction management, PDE5 inhibitors represent first-line pharmacotherapy for most men with ED [2].

Quantity Limits and Dispensing Rules

Fallon Health applies quantity limits to all PDE5 inhibitors on its formulary. The standard limit is 6 tablets per 30-day period for sildenafil 25 mg, 50 mg, or 100 mg. Some employer-sponsored plans through FCHP allow up to 12 tablets per month, but this varies by benefit design.

These quantity limits reflect both cost-containment strategy and clinical guidance. The prescribing information for sildenafil recommends dosing approximately one hour before sexual activity, with a maximum recommended frequency of once daily [3]. A limit of 6 to 12 tablets per month aligns with on-demand use patterns documented in clinical practice.

Members who need quantities exceeding the standard limit can request a quantity limit exception. The prescriber must provide clinical justification explaining why higher quantities are medically necessary. Examples include patients using lower-dose sildenafil (25 mg) for pulmonary arterial hypertension off-label, though PAH dosing uses a separate NDC and is typically covered under a different formulary category entirely.

Mail-order pharmacy options through Fallon Health's preferred pharmacy network allow 90-day fills, which can reduce per-tablet cost and improve convenience. The 90-day quantity limit is typically 18 to 36 tablets depending on the plan's monthly allowance.

Medicare Advantage Plans Through Fallon Health

Federal law creates a significant gap for Medicare beneficiaries seeking ED drug coverage. Under the Medicare Prescription Drug Improvement and Modernization Act of 2003, Medicare Part D plans are prohibited from covering drugs used for erectile dysfunction [4]. This exclusion applies to sildenafil (when prescribed for ED), tadalafil (Cialis), vardenafil (Levitra/Staxyn), and avanafil (Stendra).

Fallon Health offers several Medicare Advantage plans in Massachusetts, including Fallon Medicare Plus and NaviCare. None of these plans cover sildenafil for erectile dysfunction under Part D benefits due to the federal exclusion. The prohibition is statutory, not a Fallon Health policy decision.

There is one exception. Sildenafil prescribed for pulmonary arterial hypertension (marketed as Revatio, 20 mg tablets or injection) IS covered under Medicare Part D because the indication is not erectile dysfunction. The prescriber must document the PAH diagnosis (ICD-10 I27.0 or I27.2) and the claim must be submitted under the appropriate NDC for PAH-indication sildenafil.

Some Medicare Advantage plans offer supplemental benefits that could theoretically include ED drug coverage, but Fallon Health's current Medicare Advantage products do not include this as a supplemental benefit. Members enrolled in Fallon Medicare Advantage plans who want sildenafil for ED must pay out-of-pocket. Generic sildenafil costs approximately $0.30 to $2.00 per tablet at retail pharmacies using manufacturer discount programs or GoodRx-type coupons, making out-of-pocket payment feasible for many patients.

Generic Sildenafil vs. Brand Viagra: Cost Implications Under FCHP

Pfizer's patent on Viagra expired in 2020, and multiple generic manufacturers now produce sildenafil citrate tablets. The cost difference between brand and generic is substantial. Average wholesale price (AWP) for brand Viagra 100 mg runs approximately $82 per tablet, while generic sildenafil 100 mg averages $1.50 to $8.00 per tablet depending on manufacturer and quantity [5].

For Fallon Health members, this price disparity translates directly into formulary tier placement. Generic sildenafil at Tier 2 or 3 produces copays of $10 to $45. Brand Viagra, if covered at all, sits at Tier 4 (specialty) or requires an exception, generating copays of $75 to $150 or higher.

The FDA considers generic sildenafil bioequivalent to brand Viagra, meaning therapeutic outcomes should be identical [6]. The active ingredient, dose, route of administration, and performance characteristics (dissolution, bioavailability) meet rigorous FDA standards for generic equivalence. A 2019 meta-analysis published in the Journal of Sexual Medicine found no clinically significant differences in efficacy or adverse event rates between brand and generic PDE5 inhibitors across 14 comparative studies involving 4,218 patients [7].

For the rare patient who genuinely cannot tolerate generic formulations due to excipient sensitivities, Fallon Health's formulary exception process provides a pathway to brand coverage with appropriate documentation.

How to Verify Your Specific FCHP Coverage

Coverage details vary by plan type, employer group, and enrollment year. The most reliable verification methods for Fallon Health members are direct inquiry through official channels.

Online formulary lookup: Fallon Health's website provides a searchable drug formulary tool. Members enter their plan ID and the medication name to see tier placement, quantity limits, prior authorization requirements, and preferred alternatives.

Member services call: The phone number on the back of the Fallon Health member ID card connects to benefit specialists who can provide real-time coverage verification for specific medications.

Pharmacy benefit check: Any network pharmacy can run a test claim (sometimes called a "dry run" or eligibility check) that shows the member's copay, coverage status, and any restrictions before the prescription is actually filled.

Explanation of Benefits (EOB): After a claim processes, the EOB document shows exactly what was covered, what the member owes, and any denial reasons with appeal instructions.

Fallon Health contracts with CVS Caremark as its pharmacy benefit manager (PBM) for many plan products. Members whose pharmacy benefits are administered by CVS Caremark can also use the CVS Caremark app or website for formulary searches and cost estimates.

Alternative ED Medications Covered by Fallon Health

If sildenafil is not the right fit, Fallon Health formularies include other PDE5 inhibitors with varying coverage terms.

Tadalafil (generic Cialis): Available in 5 mg daily dosing and 10-20 mg on-demand dosing. Many FCHP plans cover generic tadalafil at Tier 2 or 3. The daily dosing option suits men who prefer spontaneity over timed dosing. A 2019 Cochrane review of 82 trials (N=47,626) found all PDE5 inhibitors demonstrated similar efficacy for ED, with tadalafil offering a longer duration of action (up to 36 hours) compared to sildenafil's 4-6 hour window [8].

Avanafil (Stendra): A newer PDE5 inhibitor with faster onset (15 minutes) and potentially fewer visual side effects. Typically Tier 3 or non-preferred on Fallon formularies; brand-only as no generic is available yet.

Non-PDE5 options: For men who fail or cannot take PDE5 inhibitors (contraindicated with nitrate therapy, for example), Fallon Health may cover alprostadil (Caverject injection or MUSE urethral suppository) with prior authorization. The 2018 AUA guideline on ED recommends intracavernosal injection as second-line therapy after PDE5 inhibitor failure [2].

Prescribers should consult the current FCHP formulary before writing prescriptions to identify which agents require fewer administrative hurdles for their patients.

The Appeals Process If Coverage Is Denied

A denial from Fallon Health is not the final word. Massachusetts state law and federal regulations (for employer-sponsored ERISA plans and Medicare Advantage) guarantee appeal rights.

Level 1 (Internal appeal): The member or prescriber submits additional clinical documentation within 60 days of the denial. A physician reviewer not involved in the original decision evaluates the appeal. Fallon Health must issue a decision within 30 days for standard appeals or 72 hours for expedited appeals.

Level 2 (External review): If the internal appeal is denied, Massachusetts law (M.G.L. c. 176O) allows members to request an independent external review through the Office of Patient Protection. The external reviewer's decision is binding on the health plan.

Formulary exception request: Separate from the appeal process, prescribers can submit a formulary exception asking the plan to cover a non-formulary drug at a lower cost-sharing tier. This requires documentation that formulary alternatives are inappropriate for the specific patient.

Success rates for PDE5 inhibitor appeals are not publicly reported by Fallon Health. Industry-wide data from the Kaiser Family Foundation shows that approximately 40-50% of prescription drug denials are overturned on internal appeal when supported by clinical documentation [9].

Sildenafil for Pulmonary Arterial Hypertension Under FCHP

Sildenafil carries FDA approval for two distinct indications: erectile dysfunction (marketed as Viagra, 25-100 mg) and pulmonary arterial hypertension (marketed as Revatio, 20 mg three times daily). Coverage rules differ dramatically between these two uses.

For PAH, sildenafil (Revatio) is covered under both commercial and Medicare formularies without the ED-specific restrictions. No quantity limit of 6-12 tablets applies. The PAH dosing regimen of 20 mg TID requires 90 tablets per month, and this quantity is standard under PAH coverage.

The SUPER-1 trial (N=278) established sildenafil's efficacy in PAH, demonstrating improved 6-minute walk distance and reduced mean pulmonary artery pressure at the 20 mg TID dose [10]. Fallon Health covers Revatio (or generic sildenafil 20 mg for PAH) under its specialty pharmacy benefit with appropriate documentation of WHO Group 1 pulmonary hypertension.

Prescribers must ensure claims are submitted with the correct diagnosis code (I27.0 or I27.2, not N52.x) and the PAH-specific NDC to avoid ED-related denials, particularly for Medicare Advantage members.

What the Evidence Says About PDE5 Inhibitor Efficacy

Understanding the clinical evidence helps members and prescribers make informed decisions about which agent to request from Fallon Health.

Sildenafil's efficacy for erectile dysfunction was established in key trials involving over 3,000 men. In the original registration trials, 69% of attempts at intercourse were successful with sildenafil 100 mg compared to 22% with placebo (P<0.001) [11]. The drug works by inhibiting phosphodiesterase type 5, increasing cyclic GMP levels in corpus cavernosum smooth muscle, and facilitating erection in the presence of sexual stimulation.

Common adverse effects include headache (16%), flushing (10%), dyspepsia (7%), nasal congestion (4%), and transient visual disturbances (3%) [11]. Serious cardiovascular events are rare in appropriately screened patients. The absolute contraindication is concurrent nitrate use (nitroglycerin, isosorbide mononitrate/dinitrate) due to risk of severe hypotension.

The 2018 AUA/SMSNA guideline states: "Clinicians should recommend PDE5 inhibitors as first-line therapy for patients with erectile dysfunction who are appropriate candidates for pharmacologic therapy" [2]. This recommendation carries a Strong evidence grade and applies regardless of ED etiology (vascular, neurogenic, psychogenic, or mixed).

For diabetic men, who represent a substantial proportion of ED patients, a meta-analysis of 12 RCTs (N=3,422) found sildenafil improved erection quality scores by 8.6 points on the IIEF-EF domain compared to placebo (95% CI: 7.1-10.1) [12]. Fallon Health does not restrict PDE5 inhibitor coverage based on ED etiology, so diabetic members receive the same formulary access as other covered individuals.